[1]郭翊.基于SCI-E 新型冠状病毒肺炎知识图谱可视化分析[J].中国中医药图书情报杂志,2021,45(3):12-19.[doi:10.3969/j.issn.2095-5707.2021.03.003]
 GUO Yi.Visualization Analysis of Knowledge Mapping of COVID-19 Based on SCI-E[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(3):12-19.[doi:10.3969/j.issn.2095-5707.2021.03.003]
点击复制

基于 SCI-E 新型冠状病毒肺炎知识图谱可视化分析

参考文献/References:

[1] 国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒感染的肺炎诊疗方案(试行第三版)的通知[EB/OL].(2020-01-23)[2020-07-30].http://www.gov.cn/zhengce/zhengceku/2020-01/23/content_5471832.htm.
[2] 中国新闻社.世卫组织建议新型肺炎暂命名为“2019-nCoV急性呼吸疾病”[EB/OL].(2020-01-31)[2020-07-30].http://www.chinanews.com/gj/2020/01-31/9074028.shtml.
[3] 新华社.世界卫生组织宣布将新型冠状病毒感染的肺炎命名为“COVID-19”[EB/OL].(2020-02-12)[2020-07-30].http://www.gov.cn/xinwen/2020-02/12/content_5478892.htm#1.
[4] 国家卫生健康委.国家卫生健康委关于修订新型冠状病毒肺炎英文命名事宜的通知[EB/OL].(2020-02-21)[2020-07-30].http://www.gov.cn/zhengce/zhengceku/2020-02/22/content_5482019.htm.
[5] 疾病预防控制局.《中国-世界卫生组织新型冠状病毒肺炎(COVID-19)联合考察报告》发布[EB/OL].(2020-02-29)[2020-07-30].http://www.nhc.gov.cn/jkj/s3578/202002/87fd92510d094e4b9bad597608f5cc2c.shtml?from=timeline&isappinstalled=0.
[6] 国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL].(2020-03-04)[2020-07-30].http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[7] 陈悦,陈超美,刘则渊,等.CiteSpace知识图谱的方法论功能[J].科学学研究,2015,33(2):242-253.
[8] 李杰,陈超美.CiteSpace:科技文本挖掘及可视化(第二版)[M].北京:首都经济贸易大学出版社,2017.
[9] CHEN C M. CiteSpace: Visualizing patterns and trends in scientific literature[EB/OL].(2019-10-25)[2020-07-30].http://cluster.ischool.drexel.edu/~cchen/citespace/download/.
[10] HUANG C L, WANG Y M, LI X W, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The Lancet, 2020,395(10223):497-506.
[11] CHEN N S, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. The Lancet, 2020,395(10223):507-513.
[12] WANG M L, CAO R Y, ZHANG L K, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J/OL]. Cell Research [2020-07-30].https://www.nature.com/articles/s41422-020-0282-0#citeas.
[13] ZOU L R, RUAN F, HUANG M X, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients[J]. N Engl J Med, 2020,382(12):1177-1179.
[14] CHEN H J, GUO J J, WANG C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records[J]. The Lancet, 2020,395(10226):809-815.
[15] WANG D W, HU B, HU C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020,323(11):1061-1069.
[16] ZHOU F, YU T, DU R H, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. The Lancet, 2020,395(10229):1054-1062.
[17] Fan E, Del Sorbo L, Goligher E C, et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2017,195(9):1253-1263.
[18] Holshue M L, Debolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States[J].N Engl J Med, 2020,382(10):929-936.
[19] Tran K, Cimon K, Severn M, et al. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review[J]. PLoS One, 2012,7(4):1-8.
[20] Danese S, Cecconi M, Spinelli A, et al. Management of IBD during the COVID-19 outbreak: resetting clinical priorities[J]. Nature Reviews Gastroenterology & Hepatology, 2020,17:253-255.
[21] Lippi G, Lavie C J, Sanchis-Gomar F. Cardiac troponin Ⅰ in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis[J]. Progress in Cardiovascular Diseases, 2020,63(3):390-391.
[22] Kuster G M, Otmar P, Thilo B, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?[J]. European Heart Journal, 2020,41(19):1801-1803.
[23] MAO R, LIANG J, SHEN J, et al. Implications of COVID-19 for patients with pre-existing digestive diseases[J]. The Lancet Gastroenterology & Hepatology, 2020,5(5):425-427.
[24] Repici A, Aragona G, Cengia G, et al. Low risk of covid-19 transmission in GI endoscopy[EB/OL].BMJ[2020-07-30].https://gut.bmj.com/content/early/2020/05/21/gutjnl-2020-321341.
[25] 姚小红,李廷源,何志承,等.新型冠状病毒肺炎(COVID-19)三例遗体多部位穿刺组织病理学研究[J].中华病理学杂志,2020,49(5):411-417.
[26] GU J Y, HAN B, WANG J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission[J]. Gastroenterology,2020,158(6):1518-1519.
[27] YANG X B, YU Y, XU J Q, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study[J]. The Lancet Respiratory Medicine, 2020,8(5):475-481.
[28] ZHENG Y Y, MA Y T, ZHANG J Y, et al. COVID-19 and the cardiovascular system[J]. Nat Rev Cardiol, 2020,17:259-260.

相似文献/References:

[1]顾小军,姜威,张子隽,等.中医药协助海外抗击新型冠状病毒肺炎疫情切入点及策略分析[J].中国中医药图书情报杂志,2020,44(3):1.[doi:10.3969/j.issn.2095-5707.2020.03.001]
 GU Xiao-jun,JIANG Wei,ZHANG Zi-jun,et al.Entry Point and Strategy Analysis of Assistance of TCM for Combating COVID-19 in Overseas Countries[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2020,44(3):1.[doi:10.3969/j.issn.2095-5707.2020.03.001]
[2]姜芬,张华敏,纪鑫毓,等.我国新型冠状病毒肺炎诊疗方案恢复期中医药组方用药规律挖掘与探讨[J].中国中医药图书情报杂志,2020,44(5):1.[doi:10.3969/j.issn.2095-5707.2020.05.001]
 JIANG Fen,ZHANG Hua-min,JI Xin-yu,et al.Mining and Discussion of TCM Prescriptions and Medication Law of Diagnosis and Treatment Plans in Recovery Period of COVID-19[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2020,44(3):1.[doi:10.3969/j.issn.2095-5707.2020.05.001]
[3]张宇,张华敏,刘思鸿,等.基于CNKI的中医药防治新冠肺炎载文特点及主题聚类分析[J].中国中医药图书情报杂志,2021,45(1):1.[doi:10.3969/j.issn.2095-5707.2021.01.001]
 ZHANG Yu,ZHANG Hua-min,LIU Si-hong,et al.Cluster Analysis on Article Characteristics and Themes of TCM Prevention and Treatment for COVID-19 Based on CNKI[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(3):1.[doi:10.3969/j.issn.2095-5707.2021.01.001]
[4]周志伟,李海英,陈跃来,等.基于Web of Science核心合集数据库的中医药治疗新型冠状病毒肺炎可视化分析[J].中国中医药图书情报杂志,2021,45(3):6.[doi:10.3969/j.issn.2095-5707.2021.03.002]
 ZHOU Zhi-wei,LI Hai-ying,CHEN Yue-lai,et al.Visualization Analysis of COVID-19 Treated with TCM Based on Web of Science Core Collection[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(3):6.[doi:10.3969/j.issn.2095-5707.2021.03.002]
[5]侯丽娟,杨静.新冠肺炎疫情下公共图书馆新媒体服务案例解析——以太原市图书馆为例[J].中国中医药图书情报杂志,2021,45(3):40.[doi:10.3969/j.issn.2095-5707.2021.03.009]
 HOU Li-juan,YANG Jing.Analysis on New Media Services in Public Libraries under COVID-19 - Taking Taiyuan Library as an Example[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(3):40.[doi:10.3969/j.issn.2095-5707.2021.03.009]
[6]蔡梦圆,杨丽,陈骥*.中医英译在中医药国际传播中的作用与思考——以3个新型冠状病毒肺炎中医诊疗方案英译为例[J].中国中医药图书情报杂志,2021,45(6):35.[doi:10.3969/j.issn.2095-5707.2021.06.008]
 CAI Meng-yuan,YANG Li,CHEN Ji*.Role and Thinking of Chinese-English Translation of TCM in the International Communication of TCM -Taking the English Translation of Three TCM Diagnosis and Treatment Plans for COVID-19 as Examples[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(3):35.[doi:10.3969/j.issn.2095-5707.2021.06.008]

备注/Memo

收稿日期:2020-09-09

第一作者:郭翊,E-mail: jerryguoe@163.com

更新日期/Last Update:

2021-05-25